跳至主要内容
临床试验/NCT04120064
NCT04120064终止1 期

Treatment of Vitamin D Deficiency With Large Bolus Cholecalciferol in the Outpatient Setting

Parkview Medical Center1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年1月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
终止
入组人数
60
试验地点
1
主要终点
Efficacy of treatment of vitamin D deficiency over a one year time frame: normalization of vitamin D levels above 30ng/mL

研究概览

简要总结

Comparing two treatment regimens (solitary large dose vs daily smaller dose) in patients diagnosed with vitamin D deficiency.

详细描述

Study is looking at patients with diagnosed vitamin D deficiency (<20ng/mL). Participants are healthy adults between 18 and 75. No diagnosis of cancer, pregnancy, hypercalcemia, hyperparathyroidism, gastrointestinal absorption disorder, or chronic kidney disease and not taking medications for seizures or osteoporosis. Participants are randomized into two treatment groups: (1) 5,000IU cholecalciferol daily or (2) one-time 300,000 international units (IU) cholecalciferol. Vitamin D level, calcium level, and renal function are measure one week after initiating treatment and then at 3 months, 6 months, 9 months, and 12 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 18-75yrs old
  • serum 25(OH)-vitamin D level <20ng/mL
  • patient of Parkview Adult Medicine clinic
  • not currently on cholecalciferol >2,000IU daily
  • no ergocalciferol administration within last week

排除标准

  • history of hypercalcemia or hyperparathyroidism
  • history of chronic kidney disease with baseline creatinine >1.1
  • history of gastric absorption abnormalities
  • history of Paget's disease or osteomalacia
  • history of thyrotoxicosis
  • known malignancy
  • currently pregnant
  • taking medications for osteoporosis or seizures
  • taking more than 1200mg/day of calcium
  • inpatient hospitalization at the initiation of study meds

研究组 & 干预措施

Large bolus

Experimental

干预措施: Cholecalciferol (Drug)

Standard

Active Comparator

干预措施: Cholecalciferol (Drug)

结局指标

主要结局

Efficacy of treatment of vitamin D deficiency over a one year time frame: normalization of vitamin D levels above 30ng/mL

时间窗: 12months

Looking for normalization of vitamin D levels

次要结局

  • Duration of efficacy after starting vitamin D replacement as monitored at one week and then three month intervals for one year(1 week, 3 months, 6 months, 9 months, 12 months)
  • Compliance with therapy as measured by the reported number of missed doses at one week on therapy and then every three months for a year(1 week, 3 months, 6 months, 9 months, 12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Doug Duffee

Administrator

Parkview Medical Center

研究点 (1)

Loading locations...

相似试验